In Slovakia, the research & development by business enterprise, pharmaceutical industry in constant ppp $ stands at 5.33 million, reflecting an increase of 1.38 million (35.0%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Slovakia
No matching regions
Similar regions to Slovakia
Business R&D pharmaceutical in constant PPP $
More indicators for Slovakia
Government R&D in security as % of government support
1.88%
+0.1%
(2021)
Higher-education-finacing R&D financed by general university in local currency
1,714.27M
+5.91M
(2021)
R&D financed by rest of the world in local currency
1,274.33M
+76.63M
(2021)
Government R&D financed by rest of the world in local currency
210.63M
+10.03M
(2021)
Business R&D financed by rest of the world in local currency
761.70M
-23.04M
(2021)
Non-profit R&D growth rate
-6.52%
-102.02%
(2022)
Slovakia Business R&D pharmaceutical in constant PPP $ between 2010 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 5.33M | +1.38M |
| 2020 | 3.95M | -0.79M |
| 2019 | 4.74M | -0.45M |
| 2018 | 5.19M | -0.91M |
| 2017 | 6.10M | -4.91M |
| 2016 | 11.01M | +4.68M |
| 2015 | 6.33M | -2.23M |
| 2014 | 8.56M | +4.36M |
| 2013 | 4.20M | -14.91M |
| 2012 | 19.11M | -7.31M |
| 2011 | 26.42M | +2.95M |
| 2010 | 23.47M |